Galderma Group AG
F:PY30
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Galderma Group AG
F:PY30
|
CH |
|
N
|
Northern Trust Corp
XBER:NT4
|
US |
|
Compagnie de Saint Gobain SA
LSE:COD
|
FR |
|
A
|
Altria Group Inc
F:PHM7
|
US |
|
N
|
Nippon Television Holdings Inc
XMUN:NP9
|
JP |
|
G
|
Graham Holdings Co
DUS:WPOB
|
US |
|
K
|
KCE Electronics PCL
SET:KCE
|
TH |
|
Aya Gold & Silver Inc
NASDAQ:AYA
|
CA |
|
Global Education Communities Corp
OTC:GECSF
|
CA |
|
A
|
Adobe Inc
XHAM:ADB
|
US |
|
J
|
Japan Post Bank Co Ltd
F:5JP
|
JP |
Wall St Price Targets
PY30 Price Targets Summary
Galderma Group AG
According to Wall Street analysts, the average 1-year price target for PY30 is 39.56 EUR with a low forecast of 31.83 EUR and a high forecast of 57.07 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PY30's stock price target?
Price Target
39.56
EUR
According to Wall Street analysts, the average 1-year price target for PY30 is 39.56 EUR with a low forecast of 31.83 EUR and a high forecast of 57.07 EUR.
What is the Revenue forecast for Galderma Group AG?
Projected CAGR
13%
Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 13%.
What is the Operating Income forecast for Galderma Group AG?
Projected CAGR
20%
Over the last 3 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 8 years is 20%.
What is the Net Income forecast for Galderma Group AG?
Projected CAGR
27%
The compound annual growth rate for Net Income over the next 8 years is 27%.
